Synthesis, in vitro and in vivo antitumor activity of pyrazole-fused 23-hydroxybetulinic acid derivatives

Hengyuan Zhang; Peiqing Zhu; Jie Liu; Yan Lin; Hequan Yao; Jieyun Jiang; Wencai Ye; Xiaoming Wu; Jinyi Xu

doi:10.1016/j.bmcl.2014.11.058

Synthesis, in vitro and in vivo antitumor activity of pyrazole-fused 23-hydroxybetulinic acid derivatives

Hengyuan Zhang
, Peiqing Zhu
, Jie Liu
, Yan Lin
, Hequan Yao
, Jieyun Jiang
, Wencai Ye
, Xiaoming Wu
, Jinyi Xu

Microbiology, Immunology, and Molecular Genetics

Research output: Contribution to journal › Article › peer-review

35 Scopus citations

Abstract

A collection of pyrazole-fused 23-hydroxybetulinic acid derivatives were designed, synthesized and evaluated for their antitumor activity. Most of the newly synthesized compounds exhibited significant antiproliferative activity. Especially compound 15e displayed the most potent activity with the IC₅₀ values of 5.58 and 6.13 μM against B16 and SF763 cancer cell lines, respectively. Furthermore, the significant in vivo antitumor activity of 15e was validated in H22 liver cancer and B16 melanoma xenograft mouse models. The structure-activity relationships of these 23-hydroxybetulinic acid derivatives were also discussed based on the present investigation.

Original language	English
Pages (from-to)	728-732
Number of pages	5
Journal	Bioorganic and Medicinal Chemistry Letters
Volume	25
Issue number	3
DOIs	https://doi.org/10.1016/j.bmcl.2014.11.058
State	Published - Feb 1 2015

Bibliographical note

Publisher Copyright:
© 2014 Elsevier Ltd. All rights reserved.

Funding

The project was funded by the National Natural Science Foundation of China (No. 81273377 ), Key Laboratory for the Chemistry and Molecular Engineering of Medicinal Resources (Guangxi Normal University), Ministry of Education of China (No. CMEMR2013-B05 ), the Project for Research and Innovation of Graduates in Universities of Jiangsu Province (CXLX13_306) and the Project Program of State Key Laboratory of Natural Medicines, China Pharmaceutical University (No.SKLNMZZCX201404).

Funders	Funder number
Project for Research and Innovation of Graduates in Universities of Jiangsu Province	CXLX13_306
National Natural Science Foundation of China (NSFC)	81273377
Ministry of Education of the People's Republic of China	CMEMR2013-B05
Guangxi Normal University
State Key Laboratory of Natural Medicines, China Pharmaceutical University
State Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

23-Hydroxybetulinic acid
Antiproliferative activity
Antitumor activity
In vivo
Pyrazole

ASJC Scopus subject areas

Biochemistry
Molecular Medicine
Molecular Biology
Pharmaceutical Science
Drug Discovery
Clinical Biochemistry
Organic Chemistry

Access to Document

10.1016/j.bmcl.2014.11.058

Cite this

@article{e5ffba8a97a9457f9ef7364e6acce9c1,

title = "Synthesis, in vitro and in vivo antitumor activity of pyrazole-fused 23-hydroxybetulinic acid derivatives",

abstract = "A collection of pyrazole-fused 23-hydroxybetulinic acid derivatives were designed, synthesized and evaluated for their antitumor activity. Most of the newly synthesized compounds exhibited significant antiproliferative activity. Especially compound 15e displayed the most potent activity with the IC50 values of 5.58 and 6.13 μM against B16 and SF763 cancer cell lines, respectively. Furthermore, the significant in vivo antitumor activity of 15e was validated in H22 liver cancer and B16 melanoma xenograft mouse models. The structure-activity relationships of these 23-hydroxybetulinic acid derivatives were also discussed based on the present investigation.",

keywords = "23-Hydroxybetulinic acid, Antiproliferative activity, Antitumor activity, In vivo, Pyrazole",

author = "Hengyuan Zhang and Peiqing Zhu and Jie Liu and Yan Lin and Hequan Yao and Jieyun Jiang and Wencai Ye and Xiaoming Wu and Jinyi Xu",

year = "2015",

month = feb,

day = "1",

doi = "10.1016/j.bmcl.2014.11.058",

language = "English",

volume = "25",

pages = "728--732",

number = "3",

}

TY - JOUR

T1 - Synthesis, in vitro and in vivo antitumor activity of pyrazole-fused 23-hydroxybetulinic acid derivatives

AU - Zhang, Hengyuan

AU - Zhu, Peiqing

AU - Liu, Jie

AU - Lin, Yan

AU - Yao, Hequan

AU - Jiang, Jieyun

AU - Ye, Wencai

AU - Wu, Xiaoming

AU - Xu, Jinyi

PY - 2015/2/1

Y1 - 2015/2/1

N2 - A collection of pyrazole-fused 23-hydroxybetulinic acid derivatives were designed, synthesized and evaluated for their antitumor activity. Most of the newly synthesized compounds exhibited significant antiproliferative activity. Especially compound 15e displayed the most potent activity with the IC50 values of 5.58 and 6.13 μM against B16 and SF763 cancer cell lines, respectively. Furthermore, the significant in vivo antitumor activity of 15e was validated in H22 liver cancer and B16 melanoma xenograft mouse models. The structure-activity relationships of these 23-hydroxybetulinic acid derivatives were also discussed based on the present investigation.

AB - A collection of pyrazole-fused 23-hydroxybetulinic acid derivatives were designed, synthesized and evaluated for their antitumor activity. Most of the newly synthesized compounds exhibited significant antiproliferative activity. Especially compound 15e displayed the most potent activity with the IC50 values of 5.58 and 6.13 μM against B16 and SF763 cancer cell lines, respectively. Furthermore, the significant in vivo antitumor activity of 15e was validated in H22 liver cancer and B16 melanoma xenograft mouse models. The structure-activity relationships of these 23-hydroxybetulinic acid derivatives were also discussed based on the present investigation.

KW - 23-Hydroxybetulinic acid

KW - Antiproliferative activity

KW - Antitumor activity

KW - In vivo

KW - Pyrazole

UR - https://www.scopus.com/pages/publications/84920738277

UR - https://www.scopus.com/pages/publications/84920738277#tab=citedBy

U2 - 10.1016/j.bmcl.2014.11.058

DO - 10.1016/j.bmcl.2014.11.058

M3 - Article

C2 - 25529742

AN - SCOPUS:84920738277

SN - 0960-894X

VL - 25

SP - 728

EP - 732

JO - Bioorganic and Medicinal Chemistry Letters

JF - Bioorganic and Medicinal Chemistry Letters

IS - 3

ER -

Synthesis, in vitro and in vivo antitumor activity of pyrazole-fused 23-hydroxybetulinic acid derivatives

Abstract

Bibliographical note

Funding

UN SDGs

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this